NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.

@article{Hoppe2018NCCNGI,
  title={NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.},
  author={Richard T. Hoppe and Ranjana Hira Advani and Weiyun Z. Ai and Richard Frederick Ambinder and Patricia A Aoun and Philippe F Armand and Celeste M Bello and Cecil M. Benitez and Philip Jay Bierman and Robert Chen and Bouthaina Dabaja and Robert Dean and Andres Forero and Leo I Gordon and Francisco J Hernandez-Ilizaliturri and Ephraim P. Hochberg and Jiayi Huang and Patrick Gerard Johnston and Mark S. Kaminski and Vaishalee Padgaonkar Kenkre and Nadia Khan and Kami J. Maddocks and David G Maloney and Monika L. Metzger and Joseph O. Moore and David Morgan and Craig H. Moskowitz and Carolyn M Mulroney and Rachel A Rabinovitch and Stuart E Seropian and Randa Tao and Jane N. Winter and Joachim Yahalom and Jennifer L Burns and Ndiya Ogba},
  journal={Journal of the National Comprehensive Cancer Network : JNCCN},
  year={2018},
  volume={16 3},
  pages={245-254}
}
The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide recommendations for the management of adult patients with HL. The NCCN Guidelines Panel meets at least annually to review comments from reviewers within the NCCN Member Institutions, examine relevant data, and reevaluate and update the recommendations. These NCCN Guidelines… CONTINUE READING